|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2750 GBX | -3.51% |
|
-8.33% | -11.29% |
| 07/01 | EnSilica hails "solid" half-year; Aptamer revenue up | AN |
| 07/01 | Solvonis Therapeutics plc Receives Notice of Allowance from the United States Patent and Trademark Office | CI |
| Capitalization | 1.87Cr 2.51Cr 2.16Cr 2Cr 3.48Cr 228.43Cr 3.74Cr 23Cr 9.12Cr 108.76Cr 9.43Cr 9.23Cr 397.45Cr | P/E ratio 2025 * |
-
| P/E ratio 2026 * | - |
|---|---|---|---|---|---|
| Enterprise value | 1.33Cr 1.78Cr 1.53Cr 1.42Cr 2.47Cr 161.77Cr 2.65Cr 16Cr 6.46Cr 77Cr 6.68Cr 6.54Cr 281.47Cr | EV / Sales 2025 * |
-
| EV / Sales 2026 * | - |
| Free-Float |
55.29% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
More press releases
| 1 day | -3.51% | ||
| 1 week | -8.33% | ||
| Current month | -11.29% | ||
| 1 month | -1.79% | ||
| 3 months | -21.43% | ||
| 6 months | -8.33% | ||
| Current year | -11.29% |
| 1 week | 0.27 |  | 0.33 |
| 1 month | 0.24 | | 0.33 |
| Current year | 0.27 | | 0.33 |
| 1 year | 0.11 | | 0.4 |
| 3 years | 0.1 | | 13.9 |
| 5 years | 0.1 | | 22.46 |
| 10 years | 0.1 | | 22.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anthony Tennyson
CEO | Chief Executive Officer | - | 02/05/2024 |
Zhanna Vuilova
CTO | Chief Tech/Sci/R&D Officer | - | - |
Anjeza Kuhar
ADM | Chief Administrative Officer | - | 01/12/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Tennyson
BRD | Director/Board Member | - | 02/05/2024 |
Nicholas Nelson
CHM | Chairman | 61 | 15/03/2024 |
Dennis Purcell
CHM | Chairman | 70 | 26/09/2024 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.51% | -8.33% | +41.03% | -98.02% | 2.6Cr | |
| -2.36% | -3.50% | -3.05% | +11.52% | 4.89TCr | |
| -1.49% | -1.95% | +20.43% | +7.77% | 4.05TCr | |
| -0.03% | +0.09% | +60.98% | +27.62% | 3.74TCr | |
| -0.71% | -3.69% | +20.76% | +39.16% | 3.1TCr | |
| -2.43% | +1.38% | +198.54% | +337.70% | 2.33TCr | |
| -1.16% | +2.67% | +81.09% | +163.02% | 1.72TCr | |
| Average | -1.64% | -0.45% | +59.97% | +69.82% | 2.83TCr | |
| Weighted average by Cap. | -1.34% | -0.10% | +48.48% | +69.48% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | -54.62L -73.36L -63.01L -58.46L -1.02Cr -67Cr -1.09Cr -6.75Cr -2.66Cr -32Cr -2.75Cr -2.69Cr -115.98Cr | -40.33L -54.16L -46.52L -43.17L -75.08L -49Cr -80.68L -4.99Cr -1.96Cr -23Cr -2.03Cr -1.99Cr -86Cr |
More financial data
* Estimated data
Employees
3
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/26/19 | 0.2750 p | -3.51% | 1,92,34,754 |
| 16/26/16 | 0.2850 p | -3.39% | 1,67,57,380 |
| 15/26/15 | 0.2950 p | 0.00% | 86,51,797 |
| 14/26/14 | 0.2950 p | -0.67% | 1,97,84,200 |
| 13/26/13 | 0.2970 p | -1.00% | 6,18,79,180 |
Delayed Quote London S.E., January 19, 2026 at 10:05 pm IST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.002850GBP
Average target price
0.0140GBP
Spread / Average Target
+391.23%
Annual profits - Rate of surprise
- Stock Market
- Equities
- SVNS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition